AMRI completes purchase of plants in India

Albany Molecular Research Inc. said this morning the purchase of the two pharmaceutical manufacturing plants, in Aurangabad and Navi Mumbai, India, has been completed.

The purchase was announced May 21. AMRI paid $11 million for the two plants and for additional land that will allow for expansion.

The company said it will invest $15 million over the next three years to expand and upgrade the plant in Aurangabad. Upgrades include improvements to wastewater treatment facilities, environmental and safety systems and procedures, and expansion and improvement of intermediate intermediates and active pharmaceutical ingredient manufacturing capabilities.

AMRI also said Prasad S. Raje had assumed leadership responsibility for the manufacturing activities in India and is transferring from Syracuse to AMRI’s Mumbai office. He will report to Jonathan Evans, AMRI’s vice president for pharmaceutical development and manufacturing.

Raje is a native of Mumbai, and has held positions at AMRI facilities in Mount Prospect, Ill., and in Albany. Before joining AMRI, Raje was a senior research scientist at Abbott Laboratories.